All other professional, scientific and technical activities n.e.c.
PHARMACOM AS
Revenue 2024
NOK 0
Operating profit
NOK −181,000
Equity
NOK 173,000
Incorporated
2011
Share capital
NOK 100,000
Key figures · 2024
Current ratio
0.37
Equity ratio
34.1%
Key figures over time · 2024
| Key figures | 2024 | Trend |
|---|---|---|
| Lønnsomhet | ||
| Return on assets (%%) | -35.6% | |
| Likviditet | ||
| Current ratio | 0.37 | |
| Working capital | −210k | |
| Soliditet | ||
| Equity ratio (%%) | 34.1% | |
| Debt-to-equity ratio | 1.93 | |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.